Corton Capital Inc. Exact Sciences Corp Transaction History

Corton Capital Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$47.19 - $70.77 $181,870 - $272,747	-3,854 Reduced 45.98%	4,528 $307,000
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $13,627 - $23,864	-449 Reduced 5.08%	8,382 $414,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $53,613 - $82,793	1,677 Added 23.44%	8,831 $287,000
Q2 2022 Aug 15, 2022	SELL	$35.61 - $76.23 $25,995 - $55,647	-730 Reduced 9.26%	7,154 $282,000
Q1 2022 May 16, 2022	BUY	$57.56 - $82.54 $453,803 - $650,745	7,884 New	7,884 $551,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

Stay updated on Corton Capital Inc. with notifications on news.